Advocacy Actions

2020-12-16 > Beijing

Meeting with the Centre of Medical Device Evaluation on Innovative Medical Device Registration

On 16 December, the Chamber attended the Innovative Medical Device Registration Meeting held by the Centre for Medical Device Evaluation.

Read more
2020-12-15 > Beijing

Comments on CMDE’s Public Consultation on the Technical Guidance on the Usage of Overseas Clinical Trial Data of In Vitro Diagnostic Reagents (Draft for Comments)

On 15 December, the medical device sector submitted the comments on the Technical Guidance on the Usage of Overseas Clinical Trial Data of In Vitro Diagnostic Reagents (Draft for Comments) published by the Centre for Medical Device Evaluation.

Read more
2020-12-15 > Beijing

Comments on the NMPA’s Public Consultation on the Dynamical Adjustment Working Procedure of Medical Device Classification Catalog (Draft for Comments)

On 15 December, the medical device sector sent comments on the Dynamical Adjustment Working Procedure of Medical Device Classification Catalog (Draft for Comments) released by the National Medical Products Administrtaion for public consultation.

Read more
2020-12-04 > Beijing

Meeting with the Centre for Drug Re-evaluation on Medical Device Vigilance

On 4 December, the medical device sector had a meeting with the Centre for Drug Re-evaluation on medical device vigilance in China.

Read more
2020-12-03 > Beijing

Meeting with the China National Centre for Biotechnology Development on Human Genetic Resources Management

On 3 December, the delegation of the medical device sector had a meeting with the China National Centre for Biotechnology Development.

Read more
2020-12-02 > Beijing

5th China Medical Device Vigilance Conference

The 5th China Medical Device Vigilance Conference was held on 2 December.

Read more
2020-11-25 > Beijing

Advocacy Letter to the State Administration for Market Regulation on Medical Devices Remote Inspection During COVID-19

On 25 November, the medial device sector submitted an advocacy letter to the State Administration for Market Regulation on medical devices remote inspection during COVID-19.

Read more
2020-11-20 > Beijing

COCIR SG presented at CIMDR Plenary, raising industry recommendations

COCIR SG presented at CIMDR Plenary, raising industry recommendations

Read more
2020-11-16 > Beijing

Meeting with the Centre for Medical Device Evaluation on the Technical Review Guideline for Change of Administrative Licensing Items of In Vitro Diagnostic Reagents (Draft)

On 16th November, the Chamber had a meeting with the Centre for Medical Device Evaluation on the Technical Review Guideline for Change of Administrative Licensing Items of In Vitro Diagnostic Reagents (Draft).

Read more
2020-11-12 > Beijing

Comments on the NMPA's Public Consultation on the National Medical Device Quality Sampling Inspection Work Procedure (Draft for Comments)

On 12th November, the medical device sector submitted comments on the National Medical Device Quality Sampling Inspection Work Procedure (Draft for Comments) to the National Medical Products Administration.

Read more